Literature DB >> 9530147

Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice.

M A Meijssen1, S L Brandwein, H C Reinecker, A K Bhan, D K Podolsky.   

Abstract

Intestinal epithelial cells may be actively involved in the immunoregulatory pathways leading to intestinal inflammation. The aim of this study was to assess expression by intestinal epithelial cells of cytokines with potential involvement in the development of intestinal inflammation in interleukin (IL)-2-deficient [(-/-)] mice. Wild-type mice, mice heterozygous for the disrupted IL-2 gene, and IL-2(-/-) mice were studied at 6, 16, and 24 wk of age. The mRNA levels of transforming growth factor-beta 1 (TGF-beta 1), tumor necrosis factor-alpha (TNF-alpha), IL-1 beta, IL-6, IL-15, KC, JE, and CD14 in colonic and small intestinal epithelial cells were assessed by Northern blot analysis. CD14 was also measured by Western blotting and reverse transcriptase polymerase chain reaction (RT-PCR). TGF-beta 1 mRNA was constitutively expressed in both colonic and small intestinal epithelial cells with increased expression in the colonic epithelium of colitic mice. CD14 was detected only in colonic epithelial cells, and mRNA levels increased severalfold in IL-2(-/-) mice with colitis. Northern analysis demonstrated increased levels of TGF-beta 1 and CD14 mRNA in colonic epithelial cells of IL-2(-/-) mice before the development of signs of colitis. CD14 mRNA and protein expression in the epithelial cells of colitic mice were confirmed by RT-PCR and Western blot analysis of isolated cells. In addition, IL-2(-/-) mice also expressed increased levels of IL-15 mRNA in small intestinal and colonic epithelial cells compared with heterozygous control mice. TNF-alpha, IL-1 beta, IL-6, KC, and JE mRNAs were only detectable in colonic epithelial cells of mice after the onset of colitis. Enhanced expression of TGF-beta 1, IL-15, and CD14 by colonic epithelial cells may play a role in the subsequent development of colitis in IL-2(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530147     DOI: 10.1152/ajpgi.1998.274.3.G472

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Intestinal trefoil factor confers colonic epithelial resistance to apoptosis.

Authors:  D R Taupin; K Kinoshita; D K Podolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis.

Authors:  Julia Preising; David Philippe; Marita Gleinser; Hua Wei; Stephanie Blum; Bernhard J Eikmanns; Jan-Hendrik Niess; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2010-03-12       Impact factor: 4.792

3.  Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology.

Authors:  Linda Chia-Hui Yu; Jin-Town Wang; Shu-Chen Wei; Yen-Hsuan Ni
Journal:  World J Gastrointest Pathophysiol       Date:  2012-02-15

4.  Protective action of NADPH oxidase inhibitors and role of NADPH oxidase in pathogenesis of colon inflammation in mice.

Authors:  Rima Ramonaite; Jurgita Skieceviciene; Simonas Juzenas; Violeta Salteniene; Juozas Kupcinskas; Paulius Matusevicius; Vilmante Borutaite; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

5.  Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells.

Authors:  A Andoh; H Takaya; J Makino; H Sato; S Bamba; Y Araki; K Hata; M Shimada; T Okuno; Y Fujiyama; T Bamba
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

6.  Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation.

Authors:  Christian-U Riedel; Francis Foata; David Philippe; Oskar Adolfsson; Bernhard-J Eikmanns; Stephanie Blum
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

7.  Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis.

Authors:  Cesar F Ortega-Cava; Shunji Ishihara; Mohammad A K Rumi; M M Aziz; Hideaki Kazumori; Takafumi Yuki; Yoshiyuki Mishima; Ichiro Moriyama; Chikara Kadota; Naoki Oshima; Yuji Amano; Yasunori Kadowaki; Norihisa Ishimura; Yoshikazu Kinoshita
Journal:  Clin Vaccine Immunol       Date:  2006-01

8.  CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited.

Authors:  D P Funda; L Tucková; M A Farré; T Iwase; I Moro; H Tlaskalová-Hogenová
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 9.  Toll-like receptors in inflammatory bowel diseases: a decade later.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

10.  Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells.

Authors:  T Kirkegaard; G Pedersen; T Saermark; J Brynskov
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.